Medline Inc. (MDLN)Healthcare | Medical Instruments & Supplies | Northfield, United States | NasdaqGS
40.58 USD
-0.46
(-1.121%) ⇩
(July 13, 2026, 4 p.m.
EDT)
After hours: 40.00 -0.58 (-0.580%) ⇩ (July 13, 2026, 7:46 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 4:03 a.m. EDT
The immediate outlook is clouded by severe technical weakness and a lack of fundamental support. Although the stock recently rallied off lows, it remains trapped below its 200-day moving average, and the recent price action shows a failure to sustain gains above key resistance levels. More concerning is the stark divergence between the company's performance and the market's reaction: while revenue grew 10.7%, earnings contracted sharply by nearly 60%, dragging the trailing P/E to a bloated 35.7x. This earnings miss, combined with a massive secondary share issuance that dilutes existing owners, has shattered investor confidence. The options market confirms this pessimism, with traders loading up on cheap puts expecting further deterioration. Without a clear turnaround in profitability or a resolution to the dilution concerns, the risk-reward profile remains skewed heavily against buyers. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.156222 |
| AutoETS | 0.156265 |
| MSTL | 0.158899 |
| AutoTheta | 0.169382 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 43% |
| H-stat | 2.20 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.152 |
| Excess Kurtosis | -0.37 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 65.311 |
| Revenue per Share | 34.444 |
| Market Cap | 72,304,230,400 |
| Trailing P/E | 35.29 |
| Forward P/E | 24.36 |
| Profit Margins | 3.32% |
| Website | https://www.medline.com |
As of July 11, 2026, 4:03 a.m. EDT: Speculators are aggressively positioning for downside protection, evidenced by massive open interest in out-of-the-money puts (strikes 30 and 35) relative to calls. While there is some call activity at higher strikes (60), the put volume dominates, particularly in the January 2027 expiration where new flow suggests a bet on significant declines. Implied volatility is elevated on deep puts, indicating fear of a sharp drop rather than a rally.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.0009756088 |
| Address1 | 3 Lakes Drive |
| All Time High | 50.876 |
| All Time Low | 32.815 |
| Ask | 43.82 |
| Ask Size | 2 |
| Audit Risk | 6 |
| Average Analyst Rating | 1.5 - Buy |
| Average Daily Volume10 Day | 8,736,940 |
| Average Daily Volume3 Month | 9,692,249 |
| Average Volume | 9,692,249 |
| Average Volume10Days | 8,736,940 |
| Bid | 38.3 |
| Bid Size | 2 |
| Board Risk | 6 |
| Book Value | 13.324 |
| City | Northfield |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 4 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 40.58 |
| Current Ratio | 4.409 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 41.99 |
| Day Low | 40.35 |
| Debt To Equity | 65.311 |
| Display Name | Medline |
| Earnings Call Timestamp End | 1,785,960,000 |
| Earnings Call Timestamp Start | 1,785,960,000 |
| Earnings Quarterly Growth | -0.599 |
| Earnings Timestamp | 1,785,933,000 |
| Earnings Timestamp End | 1,785,933,000 |
| Earnings Timestamp Start | 1,785,933,000 |
| Ebitda | 3,044,000,000 |
| Ebitda Margins | 0.10446 |
| Enterprise To Ebitda | 17.333 |
| Enterprise To Revenue | 1.811 |
| Enterprise Value | 52,760,698,880 |
| Eps Current Year | 1.51035 |
| Eps Forward | 1.66614 |
| Eps Trailing Twelve Months | 1.15 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 38.3904 |
| Fifty Day Average Change | 2.189602 |
| Fifty Day Average Change Percent | 0.05703514 |
| Fifty Two Week Change Percent | 0.09756088 |
| Fifty Two Week High | 50.876 |
| Fifty Two Week High Change | -10.295998 |
| Fifty Two Week High Change Percent | -0.20237435 |
| Fifty Two Week Low | 32.815 |
| Fifty Two Week Low Change | 7.765003 |
| Fifty Two Week Low Change Percent | 0.2366297 |
| Fifty Two Week Range | 32.815 - 50.876 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,765,981,800,000 |
| Float Shares | 356,905,003 |
| Forward Eps | 1.66614 |
| Forward P E | 24.355698 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 45,000 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,782,864,000 |
| Gross Margins | 0.25858 |
| Gross Profits | 7,535,000,064 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.00208 |
| Held Percent Institutions | 0.98850995 |
| Implied Shares Outstanding | 1,781,770,141 |
| Industry | Medical Instruments & Supplies |
| Industry Disp | Medical Instruments & Supplies |
| Industry Key | medical-instruments-supplies |
| Ipo Expected Date | 2,025-12-17 |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services, such as consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. The company was founded in 1966 and is based in Northfield, Illinois. |
| Long Name | Medline Inc. |
| Market | us_market |
| Market Cap | 72,304,230,400 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_1967303892 |
| Most Recent Quarter | 1,774,656,000 |
| Net Income To Common | 966,000,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 34,703,677,914 |
| Number Of Analyst Opinions | 27 |
| Open | 41.3 |
| Operating Cashflow | 1,474,000,000 |
| Operating Margins | 0.05427 |
| Overall Risk | 4 |
| Payout Ratio | 0.0 |
| Phone | 847 949 5500 |
| Post Market Change | -0.58000183 |
| Post Market Change Percent | -1.4292799 |
| Post Market Price | 40.0 |
| Post Market Time | 1,783,986,407 |
| Previous Close | 41.04 |
| Price Eps Current Year | 26.867947 |
| Price Hint | 2 |
| Price To Book | 3.045632 |
| Price To Sales Trailing12 Months | 2.4812708 |
| Profit Margins | 0.033150002 |
| Quick Ratio | 2.343 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 1.51852 |
| Region | US |
| Regular Market Change | -0.459999 |
| Regular Market Change Percent | -1.12086 |
| Regular Market Day High | 41.99 |
| Regular Market Day Low | 40.35 |
| Regular Market Day Range | 40.35 - 41.99 |
| Regular Market Open | 41.3 |
| Regular Market Previous Close | 41.04 |
| Regular Market Price | 40.58 |
| Regular Market Time | 1,783,972,801 |
| Regular Market Volume | 3,540,562 |
| Return On Equity | 0.060500003 |
| Revenue Growth | 0.107 |
| Revenue Per Share | 34.444 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 3 |
| Shares Outstanding | 845,606,187 |
| Shares Percent Shares Out | 0.0429 |
| Shares Short | 36,298,239 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 22,771,237 |
| Short Name | Medline Inc. |
| Short Percent Of Float | 0.0932 |
| Short Ratio | 3.27 |
| Source Interval | 15 |
| State | IL |
| Symbol | MDLN |
| Target High Price | 62.0 |
| Target Low Price | 40.0 |
| Target Mean Price | 50.88889 |
| Target Median Price | 52.0 |
| Total Cash | 2,268,000,000 |
| Total Cash Per Share | 2.682 |
| Total Debt | 12,636,999,680 |
| Total Revenue | 29,140,000,768 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 1.15 |
| Trailing P E | 35.28696 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 42.19157 |
| Two Hundred Day Average Change | -1.6115685 |
| Two Hundred Day Average Change Percent | -0.038196456 |
| Type Disp | Equity |
| Volume | 3,540,562 |
| Website | https://www.medline.com |
| Zip | 60,093 |